Long-acting progestogens

被引:16
|
作者
Affandi, B [1 ]
机构
[1] Univ Indonesia, Dept Obstet & Gynaecol, Fac Med, Klin Raden Saleh 49,Div Reprod Hlth, Bangkok 10330, Thailand
关键词
progestogens; long-acting;
D O I
10.1053/beog.2002.0268
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Steroids can be administered in at least five different ways: injectables; hormone-releasing intra-uterine devices (IUDs); implants; vaginal rings; and pills. Progestogens which are synthetic steroids, are used as the main bioactive substances. Different progestogens are effective for different periods of time. Progestins in daily oral pills are effective for 24 hours. The effectiveness of a progestogen can be prolonged by incorporating it in a sustained-release system that gradually releases the hormone; therefore they can be effective up to 5 years or more. Two progestogen-only injectables are widely available in the family planning programmes, (DMPA and NET-EN) and two combined injectables, Cyclofem (DMPA + EC), and Mesigyna (NET-EN + EV). The ring is placed by the woman in her vagina, where it gradually releases hormone. Implantable contraceptives are placed just under the skin on the inside of the woman's arm. Implant capsules release the progestogen at a slow, steady rate. There are three implantables available in the market: Implanon; Norplant; and Jadelle. They are effective for 1-5 years, but then must be replaced. Natural and synthetic progestogens were first added to IUDs in the early 1970s. The main problem of long-acting progestogens is the disruption of the menstrual cycle.
引用
收藏
页码:169 / 179
页数:11
相关论文
共 50 条
  • [1] CONCEPTION CONTROL BY LONG-ACTING PROGESTOGENS - PRELIMINARY REPORT
    SIEGEL, I
    OBSTETRICS AND GYNECOLOGY, 1963, 21 (06): : 666 - &
  • [2] EFFECT OF 2 LONG-ACTING INJECTABLE PROGESTOGENS ON LACTATION IN HUMAN
    ABDELKADER, MM
    ABDELAZIZ, MT
    BAHGAT, MR
    KAMAL, I
    TALAAT, M
    ABDALLAH, M
    OSMAN, M
    ACTA BIOLOGICA ET MEDICA GERMANICA, 1975, 34 (07) : 1199 - 1204
  • [3] Long-acting sulfonylureas - long-acting hypoglycaemia
    Veitch, PC
    Clifton-Bligh, RJ
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 180 (02) : 84 - 85
  • [5] Intrinsically long-acting agents compared with long-acting chronoformulations
    Meredith, PA
    BLOOD PRESSURE MONITORING, 2000, 5 : S25 - S30
  • [6] INTRAEPITHELIAL CERVICAL NEOPLASIA IN WOMEN USING INTRAUTERINE-DEVICES AND LONG-ACTING INJECTABLE PROGESTOGENS AS CONTRACEPTIVES
    DABANCENS, A
    PRADO, R
    LARRAGUIBEL, R
    ZANARTU, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1974, 119 (08) : 1052 - 1056
  • [7] WHY ARE LONG-ACTING BETA-ADRENOCEPTOR AGONISTS LONG-ACTING
    ANDERSON, GP
    LINDEN, A
    RABE, KF
    EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (03) : 569 - 578
  • [8] LONG-ACTING NEUROLEPTICS
    CAPPADORO, R
    LEMOINE, P
    COROT, P
    PSYCHOPATHOLOGIE AFRICAINE, 1981, 17 (1-3): : 505 - 510
  • [9] LONG-ACTING CORTICOTROPHIN
    FLYNN, MJ
    BRITISH MEDICAL JOURNAL, 1967, 3 (5565): : 619 - &
  • [10] LONG-ACTING INSULINS
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1966, 1 (5500): : 1407 - +